In focus · trending topic

BIRTH CONTROL

32 stories · following the connections

Agile Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

By Nasdaq OMXAug 22, 2017, 11:30 AM UTC

Agile Therapeutics to Present at Liolios 6th Annual Gateway Conference

By Nasdaq OMXAug 16, 2017, 8:10 PM UTC

Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock

By Nasdaq OMXAug 3, 2017, 12:24 PM UTC

Agile Therapeutics Announces Proposed Offering of Common Stock

By Nasdaq OMXAug 2, 2017, 8:06 PM UTC

Agile Therapeutics Reports Second Quarter 2017 Financial Results

By Nasdaq OMXJul 28, 2017, 11:30 AM UTC

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®

By Nasdaq OMXJun 27, 2017, 12:00 PM UTC

Agile Therapeutics Reports First Quarter 2017 Financial Results

By Nasdaq OMXMay 8, 2017, 8:11 PM UTC

Agile Therapeutics to Present Additional Phase 3 Data at the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and Gynecologists

By Nasdaq OMXMay 3, 2017, 8:15 PM UTC